We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Is Fructose Fuelling the Obesity Epidemic?

By HospiMedica staff writers
Posted on 15 Jul 2008
A new study has found that overweight adults that consume large amounts of fructose experience changes in body fat and insulin sensitivity that do not occur after glucose intake.

Researchers at the University of California School of Veterinary Medicine (Davis, CA, USA) compared the metabolic and endocrine effects of high-fructose corn syrup (HFCS) with sucrose and, in a subset of subjects, with pure fructose and glucose. More...
A total of 34 men and women consumed three isocaloric meals with either sucrose- or HFCS-sweetened beverages, and blood samples were collected over 24 hours. Eight of the male subjects were also studied when fructose- or glucose-sweetened beverages were consumed.

The researchers found that in all of the subjects, 24-hour glucose, insulin, leptin, ghrelin, and triacylglycerol (TG) profiles were similar between days that sucrose or HFCS was consumed. In the men in whom the effects of four different sweeteners were compared, the 24-hour glucose and insulin responses induced by HFCS and sucrose were intermediate, between the lower responses during consumption of fructose and the higher responses during glucose. Sucrose and HFCS did not have substantially different short-term endocrine or metabolic effects. Unexpectedly, the researchers found that TG profiles after meals, which included HFCS or sucrose, were not intermediate but comparably high as after pure fructose.

"Consuming fructose-sweetened beverages during meals results in lower 24-hour circulating glucose, insulin, and leptin concentrations, and elevated triacylglycerol,” concluded lead author Peter Havel, D.V.M., Ph.D., of the department of molecular biosciences, and colleagues. "In male subjects, short-term consumption of sucrose and HFCS resulted in postprandial TG responses comparable to those induced by fructose.”

Pure fructose is found in fresh fruit, fruit juice, and preserves. However, fructose also enters our diets though HFCS (which has replaced sucrose as the predominant sweetener in beverages)--subsequently broken down in the body into 55% fructose and 45%--or via sucrose (ordinary sugar), which is also broken down into the same two sugars.


Related Links:
University of California School of Veterinary Medicine

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.